Learn more about the transformation of psychedelics into medicines
Media
Press Releases
Title
Date
Eleusis Announces Notice of Allowance for US Patent Application With Claims Covering Lead Drug Candidate ELE-Psilo
Eleusis Announces Notice of Allowance for US Patent Application With Claims Covering Lead Drug Candidate ELE-Psilo
Mar. 29, 2022
Psychedelic Science Leader Eleusis to Become Public Company in Merger with
Silver Spike Acquisition Corp. II
Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II
Jan. 20, 2022
Psychedelic Science Leader Eleusis Announces Four New Board Appointments, Further Strengthening Leadership
Psychedelic Science Leader Eleusis Announces Four New Board Appointments, Further Strengthening Leadership
Jul. 12, 2021
Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology
Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology
Jan. 11, 2021
Eleusis Launches Clinical Development of Psychedelic Infusion Therapies for Major Depressive Disorder and Acquires Kalypso Wellness Centers
Eleusis Launches Clinical Development of Psychedelic Infusion Therapies for Major Depressive Disorder and Acquires Kalypso Wellness Centers
Dec. 14, 2020